Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06605157 · ClinicalTrials.gov registry record · NA
A Multimodal Music Therapy Intervention for Engaging Persons With Severe Dementia
A NA study of Dementia Severe, sponsored by Alaine E Hernandez, PhD.
- Recruiting
- Registry status
- NA
- Development phase
- 45
- Enrollment target
- 9
- Study locations
NCT06605157: Recruiting NA study of Dementia Severe, sponsored by Alaine E Hernandez, PhD.
NCT06605157 is a NA study of Dementia Severe that is actively recruiting participants, run by Alaine E Hernandez, PhD. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 9 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06605157, a NA study of Dementia Severe, is actively recruiting participants, sponsored by Alaine E Hernandez, PhD.
- RECRUITING
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
- 9
- Study locations
Study Summary
The goal of this pilot randomized clinical trial is to learn if a music therapy treatment, called AMUSED, can improve engagement and reduce behavioral symptoms in older adults with severe dementia who live in care facilities. The main questions it aims to answer are: * Is it feasible to conduct a full-scale trial of AMUSED? * Can investigators identify the best outcome measures to assess impact on behavioral symptoms of dementia? * Does speech offer a useful indicator of treatment effectiveness? Researchers will compare a group-based music therapy treatment to a reading activity to learn if music therapy leads to greater improvements in behavioral symptoms and speech patterns. Participants will: * Participate in either music therapy (includes live music, singing, and rhythmic instrument playing) or a reading group with stories about life and nature and talk about memories. * Attend small group sessions twice a week for 12 weeks, with each session lasting 40 minutes between lunch and dinner. * Be observed and assessed for behavioral symptoms, cognition, and speech several times during treatment and at a 4-week follow-up.
Primary Outcome
The Quick Dementia Behavior Observation Scale (QD-BOS) is an 18-item observational measure (est. 3 min. to complete). Section 1 contains the 11 sub-questions from the Neuropsychiatric Inventory-Nursing Home section C "agitation/aggression" and care staff rate the presence or absence of 8 behaviors in the past week (raw score 0-8), the frequency (raw score 1-4) and severity of behaviors (raw score 1-3), total score (frequency x severity, ranges 1-12), and occupational disruptiveness of those beha
Conditions Studied
Interventions
- BEHAVIORAL AMUSED
- BEHAVIORAL Reading Aloud
Study Locations (9)
Kentucky
- Cedar Ridge Health Campus - Cynthiana
- Walker's Trail Senior Living - Danville
- University of Kentucky - Lexington
- Magnolia Springs Senior Living - Lexington
- Sayre Christian Village - Lexington
- The Homeplace at Midway - Midway
- Windsor Care Center - Mount Sterling
- Daisy Hill Senior Living - Versailles
- Thomson-Hood Veterans Center - Wilmore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2025-03-12 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What NCT06605157 shows while recruiting
NCT06605157 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Dementia Severe appearing as the primary indexed condition, and to 2 interventions - of which AMUSED is the first listed.
NCT06605157 lists 9 locations in 1 state (Kentucky).
Frequently Asked Questions
What is clinical trial NCT06605157 about?
NCT06605157 is a clinical study titled "A Multimodal Music Therapy Intervention for Engaging Persons With Severe Dementia". The goal of this pilot randomized clinical trial is to learn if a music therapy treatment, called AMUSED, can improve engagement and reduce behavioral symptoms in older adults with severe dementia who live in care facilities. The main questions it aims to answer are: * Is it feasible to conduct a f...
What is the current status of trial NCT06605157?
This trial is currently recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2025-03-12. Estimated completion is 2026-06-30.
What conditions does trial NCT06605157 study?
This clinical trial studies the following conditions: Dementia Severe.
What interventions are being tested in trial NCT06605157?
The interventions under investigation include: AMUSED (BEHAVIORAL), Reading Aloud (BEHAVIORAL).
Who is sponsoring clinical trial NCT06605157?
This trial is sponsored by Alaine E Hernandez, PhD, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06605157 being conducted?
This trial has 9 study locations across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dementia Severe
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06605157's enrollment target sits among peer trials
45 1412th of 2000 higher than 578 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI